HRH1 and Parkinson disease: Previous translational studies have indicated that the symptomatic attenuation of Parkinsonism symptoms by histamine H1-receptor antagonists such as ebastine and levocetirizine may be related to the downregulation of oxidative stress and anti-inflammatory effects [30,31].